Biotechnology - Asia-Pacific

Filter

Current filters:

Asia-Pacific

Popular Filters

126 to 150 of 163 results

AusBiotech supports discussion paper on Australian national research investment plan

15-08-2012

Biotechnology trade group AusBiotech, responding to the Australian federal government's discussion paper…

Asia-PacificBiotechnologyFinancialResearch

PharmaEngine and Nanobiotix sign Asia-Pacific deal for NBTXR3

08-08-2012

French nano-medicines group Nanobiotix has entered into a strategic partnership with PharmaEngine (TWO:…

Asia-PacificBiotechnologyLicensingNanobiotixNBTXR3OncologyPharmaceuticalPharmaEngine

EMA increases interaction with Japanese regulators

30-07-2012

The European Medicines Agency has increased its level of interaction and cooperation with medicines regulatory…

Asia-PacificBiotechnologyEuropePharmaceuticalRare diseasesRegulation

New Zealand pharma urged to capturing value from innovation

30-07-2012

New Zealand's innovative companies and research community must protect their breakthroughs, for the country…

Asia-PacificBiotechnologyPatentsPharmaceuticalResearch

Pharmaceutical supply chain in Japan sees squeezed margins

19-07-2012

Pressures felt in Japan as a result of the country's aging population, drug price revisions and patent…

Asia-PacificBiotechnologyFinancialMarkets & MarketingMergers & AcquisitionsPharmaceuticalPricing

Alnylam and Ascletis collaborate to develop ALN-VSP for liver cancers in China

15-07-2012

US RNAi therapeutics specialties Alnylam Pharmaceuticals (Nasdaq: ALNY) and Ascletis Pharmaceuticals,…

ALN-VSPAlnylam PharmaceuticalsAscletis PharmaceuticalsAsia-PacificBiotechnologyLicensingOncology

Australia's Greens want end to Big Pharma inducements

28-06-2012

Ahead of an announcement by pharma trade group Medicines Australia on a new Code of Conduct this week,…

Asia-PacificBiotechnologyMarkets & MarketingPharmaceuticalRegulation

Australian patients to benefit from new PBS listings; OTC reforms

26-06-2012

The listing of 11 prescription medicines on the Australian Pharmaceutical Benefits Scheme (PBS) has been…

Asia-PacificBiotechnologyHealthcarePharmaceuticalPricingRegulation

CSL Biotherapies indentifies likely reason for Fluvax problems

21-06-2012

Australia's largest biotech firm CSL Biotherapies, a division of CSL Limited (ASX: CSL) today presented…

Asia-PacificBiotechnologyCSL BiotherapiesCSL LimitedFluvaxMarkets & MarketingVaccines

Quintiles expands operations in China

18-06-2012

US-headquartered biopharma services provider Quintiles yesterday announced agreements to establish a…

Asia-PacificBiotechnologyFinancialPharmaceuticalQuintilesResearch

Osiris gets second approval for Prochymal, in New Zealand

15-06-2012

USA-based Osiris Therapeutics (Nasdaq: OSIR) has received a second approval to market its first-in-class…

Asia-PacificBiotechnologyImmunologicalsOsiris TherapeuticsProchymalRegulation

Australia's PIC reports to Ministers on treatment and reimbursement of similar biologics

14-06-2012

The Australian Pharmaceuticals Industry Council (PIC), with industry group members AusBiotech, Medicines…

Asia-PacificBiotechnologyGenericsPharmaceuticalPricingRegulation

Indian drugmakers group inks deal with DuBiotech

12-06-2012

The Indian Drug Manufacturers' Association (IDMA) has signed a memorandum of understanding with Dubai…

Asia-PacificBiotechnologyResearchRest of the World

Business in Japan versus to Japan, by P Reed Maurer

11-06-2012

A pharmaceutical company without a presence in Japan but with a hot new product ready for Phase III clinical…

Asia-PacificBiotechnologyMarkets & MarketingPharmaceuticalRegulation

Australia's TGA launches consultation on better medicines labeling

24-05-2012

Australia's medicine's regulator, the Therapeutic Goods Administration, has this week released a consultation…

Asia-PacificBiotechnologyGenericsPharmaceuticalRegulation

AusBiotech marks Clinical Trials Day with call for action

22-05-2012

Marking International Clinical Trials Day 2012 (May 20), Australian biotech industry trade group AusBiotech…

Asia-PacificBiotechnologyPoliticsResearch

Erythropoietin market in Japan to reach $1.54 billion by 2015

20-05-2012

The erythropoietin market in Japan is forecast to reach $1.54 billion by 2015 by analysts at TechNavio.…

Asia-PacificBiotechnologyGenericsMarkets & MarketingNephrology and HepatologyPatents

China's Hisun gains access to Enzon technology

17-05-2012

US biotech firm Enzon Pharmaceuticals (Nasdaq: ENZN) and Chinese drugmaker Zhejiang Hisun Pharmaceuticals…

Asia-PacificBiotechnologyEnzon PharmaceuticalsLicensingOncologyPEG-SN38PharmaceuticalZhejiang Hisun Pharma

Contract manufacturing in India and China backed by government policies

16-05-2012

Contract Manufacturing Organizations (CMO) will reap the rewards as pharmaceutical production becomes…

Asia-PacificBiotechnologyMarkets & MarketingPharmaceutical

Additional investment in New Zealand health welcomed by pharma trade group

15-05-2012

New Zealand Prime Minister John Key yesterday announced a number of new initiatives which came to an…

Asia-PacificBiotechnologyHealthcarePharmaceutical

Australian Biotech industry confident, despite economic woes

18-04-2012

The annual Biotechnology Industry Position Survey shows the bullish sentiment for the Australian industry's…

Asia-PacificBiotechnologyFinancialResearch

Daiichi Sankyo debuts bone cancer drug Ranmark in Japan

17-04-2012

Following National Health Insurance price listing yesterday, Japanese drug major Daiichi Sankyo (TYO:…

AmgenAsia-PacificAstraZenecaBiotechnologyDaiichi SankyodenosumabMarkets & MarketingOncologyPharmaceuticalRanmark

126 to 150 of 163 results

Back to top